Clinical Trial Update: Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism [Phase 2]

View source ↗

Summary

This clinical trial registry entry describes a Phase 2 study to evaluate neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes for Park…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mesenchymal Stem Cell-Derived Exosomes
• Neuroinduced Mesenchymal Stem Cells

Snippet

Sponsor: Biocells Medical | Conditions: Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere | Phase 2 | Status: NOT_YET_RECRUITING